330 related articles for article (PubMed ID: 30261889)
1. Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
Hopkins AM; Rowland A; Sorich MJ
BMC Med; 2018 Sep; 16(1):165. PubMed ID: 30261889
[TBL] [Abstract][Full Text] [Related]
2. Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration.
Modi ND; Abuhelwa AY; McKinnon RA; Boddy AV; Haseloff M; Wiese MD; Hoffmann TC; Perakslis ED; Rowland A; Sorich MJ; Hopkins AM
JAMA Oncol; 2022 Sep; 8(9):1310-1316. PubMed ID: 35900732
[TBL] [Abstract][Full Text] [Related]
3. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
Miller J; Ross JS; Wilenzick M; Mello MM
BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement Requirement.
Danchev V; Min Y; Borghi J; Baiocchi M; Ioannidis JPA
JAMA Netw Open; 2021 Jan; 4(1):e2033972. PubMed ID: 33507256
[TBL] [Abstract][Full Text] [Related]
5. Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation.
Hopkins AM; Modi ND; Rockhold FW; Hoffmann T; Menz BD; Veroniki AA; McKinnon RA; Rowland A; Swain SM; Ross JS; Sorich MJ
J Clin Epidemiol; 2024 Mar; 167():111263. PubMed ID: 38219810
[TBL] [Abstract][Full Text] [Related]
6. Fostering EMA's transparency policy.
Banzi R; Bertele' V; Demotes-Mainard J; Garattini S; Gluud C; Kubiak C; Ohmann C
Eur J Intern Med; 2014 Oct; 25(8):681-4. PubMed ID: 25200801
[TBL] [Abstract][Full Text] [Related]
7. EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers.
Sudlow R; Branson J; Friede T; Morgan D; Whately-Smith C
BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):73. PubMed ID: 27410386
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry.
So D; Joly Y; Knoppers BM
Public Health Genomics; 2013; 16(6):322-35. PubMed ID: 24503593
[TBL] [Abstract][Full Text] [Related]
9. A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Modi ND; Kichenadasse G; Hoffmann TC; Haseloff M; Logan JM; Veroniki AA; Venchiarutti RL; Smit AK; Tuffaha H; Jayasekara H; Manning-Bennet A; Morton E; McKinnon RA; Rowland A; Sorich MJ; Hopkins AM
BMC Med; 2023 Oct; 21(1):400. PubMed ID: 37872545
[TBL] [Abstract][Full Text] [Related]
10. Availability of Clinical Trial Data From Industry-Sponsored Cardiovascular Trials.
Murugiah K; Ritchie JD; Desai NR; Ross JS; Krumholz HM
J Am Heart Assoc; 2016 Apr; 5(4):e003307. PubMed ID: 27098969
[TBL] [Abstract][Full Text] [Related]
11. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
[TBL] [Abstract][Full Text] [Related]
12. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
[TBL] [Abstract][Full Text] [Related]
13. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
[TBL] [Abstract][Full Text] [Related]
14. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
15. Sponsor-Imposed Publication Restrictions Disclosed on ClinicalTrials.gov.
Stretton S; Lew RA; Ely JA; Snape MJ; Carey LC; Haley C; Woolley MJ; Woolley KL
Account Res; 2016; 23(2):67-78. PubMed ID: 26193425
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages.
Hopkins AM; Modi ND; Abuhelwa AY; Kichenadasse G; Kuderer NM; Lyman GH; Wiese MD; McKinnon RA; Rockhold FW; Mann A; Rowland A; Sorich MJ
JAMA Oncol; 2023 Dec; 9(12):1621-1626. PubMed ID: 37796495
[TBL] [Abstract][Full Text] [Related]
18. Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors.
Mooney LA; Fay L; DeCastro B; Zanki TA; Mansi B
Curr Med Res Opin; 2019 Jul; 35(7):1221-1230. PubMed ID: 30648455
[No Abstract] [Full Text] [Related]
19. Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe.
Rawal B; Deane BR
Curr Med Res Opin; 2014 Mar; 30(3):395-405. PubMed ID: 24168052
[TBL] [Abstract][Full Text] [Related]
20. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology.
Knox KS; Adams JR; Djulbegovic B; Stinson TJ; Tomor C; Bennet CL
Ann Oncol; 2000 Dec; 11(12):1591-5. PubMed ID: 11205468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
